The FDA has approved a new fast-acting, non-opioid pain medicine that pairs acetaminophen with naproxen. The decision marks a possible shift in acute pain care as clinicians and patients look for alternatives to opioids. Early reports highlight quick onset and broad applicability for common pain conditions. Why this FDA approval …